Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 22 (4), 241-247

Secondary Primary Prostate Cancer After Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea

Affiliations

Secondary Primary Prostate Cancer After Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea

Hyun Soo Kim et al. J Cancer Prev.

Abstract

Background: Colorectal cancer (CRC) and prostate cancer frequently occur in developed countries. There are several reports on the association between CRC and prostate cancer; however, the conclusions are inconsistent to investigate the association of the development of secondary primary prostate cancer among patients with prior primary CRC using a nationwide population-based dataset.

Methods: Patients registered in the Republic of Korea National Health Insurance System database who were diagnosed with CRC between 2007 and 2012 were followed-up until the end of 2015, and we investigated the new diagnosis secondary primary prostate cancer. We compared the incidence of prostate cancer in age-matched controls using the Cox proportional hazards models.

Results: We analyzed a total of 85,455 first primary CRC survivors. During the follow-up period of 494,222 person-years, 2,005 patients (2.30%) developed secondary primary prostate cancer (incidence rate 4.06/1,000 person-years). The median duration of follow-up was 5.78 years. Compared with the general population, CRC patients had a significantly increased risk of secondary primary prostate cancer (HR = 2.30, 95% CI = 2.18-2.43; P < 0.001). Multivariate analysis (including age, sex, body mass index, hypertension, diabetes mellitus, dyslipidemia, and income) showed that age < 55 years (HR = 20.74, 95% CI = 11.81-36.41; P < 0.001) is a significant independent predictor of secondary primary prostate cancer development.

Conclusions: Men diagnosed with colorectal cancer are at an increased risk of secondary primary prostate cancer, particularly those aged < 55 years. The data suggests that colorectal cancer patients aged < 55 years require regular screening for prostate cancer.

Keywords: Colorectal neoplasm; Prostatic neoplasm; Second primary neoplasms.

Conflict of interest statement

CONFLICTS OF INTEREST No potential conflicts of interest were disclosed.

Figures

Figure 1
Figure 1
CONSORT flow diagram of patient recruitment. CRC, colorectal cancer; NHIS, National Health Insurance System; SPPC, secondary primary prostate cancer.
Figure 2
Figure 2
Cumulative incidence of prostate cancer in colorectal cancer (CRC) patients and general population.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

References

    1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. ; Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017;3:524–48.10.1001/jamaoncol.2016.5688 - DOI - PMC - PubMed
    1. Evans HS, Møller H, Robinson D, Lewis CM, Bell CM, Hodgson SV. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut 2002;50:647–52.10.1136/gut.50.5.647 - DOI - PMC - PubMed
    1. Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 2007;16:566–71.10.1158/1055-9965.EPI-06-0782 - DOI - PubMed
    1. Lee YT, Liu CJ, Hu YW, Teng CJ, Tzeng CH, Yeh CM, et al. Incidence of second primary malignancies following colorectal cancer: a distinct pattern of occurrence between colon and rectal cancers and association of co-morbidity with second primary malignancies in a population-based cohort of 98,876 patients in Taiwan. Medicine (Baltimore) 2015;94:e1079.10.1097/MD.0000000000001079 - DOI - PMC - PubMed
    1. Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA 2017;317:2532–42.10.1001/jama.2017.7248 - DOI - PubMed

LinkOut - more resources

Feedback